Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies

Ann Surg Oncol. 2022 May 5. doi: 10.1245/s10434-022-11709-8. Online ahead of print.

Authors

Mark A Healy¹, Michael A Choti²

Affiliations

¹ Banner M.D. Anderson Cancer Center, Phoenix, Gilbert, AZ, 85234, USA.
² Banner M.D. Anderson Cancer Center, Phoenix, Gilbert, AZ, 85234, USA. michael.choti@bannerhealth.com.

PMID: 35513591
DOI: 10.1245/s10434-022-11709-8

No abstract available

Publication types

Editorial